Arteris, INC Form 4 insider transactions

Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc., reported the sale of 3,770 shares of common stock on June 9, 2025, as part of a pre-scheduled 10b5-1 trading plan.

Arteris, Inc. Director Antonio J. Viana disclosed the sale of 19,287 shares of common stock and the transfer of 21,327 shares to a family trust.

Paul L. Alpern, VP and General Counsel of Arteris, Inc., sold 423 shares of common stock for a weighted average price of $7.6618 per share, as part of a pre-arranged 10b5-1 trading plan.

Arteris, Inc. President and CEO, Charles Janac, reported the sale of 2,057 shares of common stock on June 4, 2025, as part of a pre-established 10b5-1 trading plan.

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold a total of 2,451 shares of common stock in early June 2025, pursuant to a Rule 10b5-1 trading plan.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 202 shares of common stock for $7.96 per share on June 4, 2025, as part of a pre-arranged 10b5-1 trading plan.

Arteris, Inc. Director Joachim Kunkel has reported the acquisition of 20,839 restricted stock units (RSUs) as part of his compensation, increasing his beneficial ownership to 64,595 shares.

Arteris, Inc. Director Antonio J. Viana reported the acquisition of 20,839 restricted stock units (RSUs) on June 3, 2025, as part of his compensation.

Arteris, Inc. Director Claudia F. Munce was granted 20,839 restricted stock units (RSUs) on June 3, 2025, increasing her direct beneficial ownership to 100,851 shares.

Arteris, Inc. Director Raman Chitkara has acquired 20,839 restricted stock units, increasing his beneficial ownership to 157,867 shares.

Arteris, Inc. Director Saiyed Atiq Raza has reported the acquisition of 20,839 restricted stock units (RSUs) on June 3, 2025, as part of his compensation.

Arteris, Inc. Director Wayne C. Cantwell has reported the acquisition of 34,732 restricted stock units (RSUs) as part of his compensation, aligning his interests with shareholders.

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, reported the sale of 438 shares of common stock to satisfy tax obligations arising from restricted stock unit release, while his total beneficial ownership remains substantial.

Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 612 shares of common stock at $7.7033 per share to satisfy tax obligations related to restricted stock unit vesting.

Arteris, Inc. President and CEO, K. Charles Janac, reported the sale of 1,246 shares of common stock to satisfy tax liabilities arising from the vesting of restricted stock units.

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, sold 259 shares of common stock on June 2, 2025, to cover tax obligations related to restricted stock units.

Arteris, Inc.'s CFO, Nicholas B. Hawkins, executed a sale of 11,000 shares of common stock at an average price of $7.5405, pursuant to a pre-arranged 10b5-1 trading plan.

Director Joachim Kunkel acquired 1,834 shares of Arteris, Inc. common stock on April 5, 2025, as compensation in lieu of cash retainer fees.

Arteris, Inc. CEO Charles Janac sold shares of common stock on April 2nd and 3rd, 2025, to cover tax liabilities related to the release of restricted stock units.

Nicholas Hawkins, CFO of Arteris, Inc., sold shares of common stock on April 2nd and 4th, 2025, to cover tax liabilities related to the release of restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on April 2nd and 4th, 2025, to cover tax liabilities related to the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold shares of common stock on April 2nd and 4th, 2025, to cover tax liabilities related to the release of restricted stock units.

Nicholas B. Hawkins, CFO of Arteris, Inc., sold 690 shares of common stock at a price of $8.17 per share on March 6, 2025, under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. CEO Charles Janac sold 1,973 shares of common stock at $8.19 per share on March 5, 2025, under a pre-arranged 10b5-1 trading plan.

Chief Operating Officer Laurent R. Moll of Arteris, Inc. reports selling 193 shares of common stock at $8.19 per share on March 5, 2025, under a pre-arranged 10b5-1 trading plan.

Paul L. Alpern, VP and General Counsel of Arteris, Inc., sold 406 shares of common stock at $8.17 per share on March 6, 2025, according to a Form 4 filing.

Nicholas Hawkins, CFO of Arteris, Inc., sold shares of common stock on March 3, 2025, to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. CEO Charles Janac sold 1,330 shares of common stock on March 3, 2025, to cover tax liabilities related to the release of restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold 654 shares of common stock on March 3, 2025, to cover tax liabilities arising from the release of restricted stock units.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold 276 shares of common stock on March 3, 2025, to cover tax liabilities arising from the release of restricted stock units.